ICON 9-an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy.
Osnat ElyashivJonathan A LedermannGita ParmarLaura FarrellyNicholas CounsellAmanda FeeneyFatima El-KhoulyIan MacdonaldAndreia NetoEsther Arthur-DarkwaEva BurnettGordon C JaysonLinda MileshkinCharlie GourleyShibani NicumPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2020)
ClinicalTrials.gov: NCT03278717.
Keyphrases
- phase iii
- open label
- clinical trial
- acute lymphoblastic leukemia
- acute myeloid leukemia
- double blind
- phase ii
- diffuse large b cell lymphoma
- placebo controlled
- multiple myeloma
- hodgkin lymphoma
- locally advanced
- randomized controlled trial
- study protocol
- radiation therapy
- cell therapy
- chemotherapy induced
- smoking cessation